PRSS1 and alkaline phosphatase measurement: The most recent publication, also the one with most AP patients included (N = 239), showed that serum levels of trypsinogen-2 on admission (AUC 0.726) outperformed trypsinogen-1 (AUC 0.656) [29] in predicting the development of organ dysfunction and a severe course of disease.